NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.75% | 24.57% | 23.78% | 3.87% | 9.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.75% | 24.57% | 23.78% | 3.87% | 9.22% |
| Cost of Revenue | 19.00% | 23.41% | 24.16% | 3.45% | 9.26% |
| Gross Profit | 12.48% | 29.75% | 22.29% | 5.77% | 9.04% |
| SG&A Expenses | 27.54% | 25.72% | 19.81% | 0.63% | 7.95% |
| Depreciation & Amortization | -3.88% | -4.08% | 2.67% | -3.46% | -22.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.54% | 22.83% | 22.90% | 2.82% | 7.67% |
| Operating Income | -97.58% | 231.78% | 45.41% | 81.14% | 1,375.00% |
| Income Before Tax | -165.26% | 109.16% | 13.24% | 36.50% | 63.50% |
| Income Tax Expenses | -219.70% | 126.77% | 121.99% | 119.15% | 375.00% |
| Earnings from Continuing Operations | -86.31% | 71.20% | -6.58% | 10.74% | 52.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.95% | 25.17% | -25.93% | -137.70% | -6,528.57% |
| Net Income | -67.66% | 62.21% | -13.78% | -2.64% | 35.47% |
| EBIT | -97.58% | 231.78% | 45.41% | 81.14% | 1,375.00% |
| EBITDA | 53.13% | 43.66% | 27.09% | 20.96% | 68.30% |
| EPS Basic | -67.74% | 61.54% | -13.16% | -2.00% | 35.42% |
| Normalized Basic EPS | -733.33% | 183.33% | 90.63% | 140.00% | 85.00% |
| EPS Diluted | -67.74% | 72.60% | -13.16% | 5.41% | 35.42% |
| Normalized Diluted EPS | -733.33% | 183.33% | 84.38% | 140.00% | 85.00% |
| Average Basic Shares Outstanding | -0.33% | 0.09% | 0.47% | -0.13% | 0.19% |
| Average Diluted Shares Outstanding | -0.33% | 3.31% | 2.62% | 1.15% | 0.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |